An economic evaluation of routine hepatocellular carcinoma surveillance for high-risk patients using a novel approach to modelling competing risks
View ORCID ProfileJoachim Worthington, View ORCID ProfileEmily He, View ORCID ProfileMichael Caruana, View ORCID ProfileStephen Wade, View ORCID ProfileBarbara de Graaff, View ORCID ProfileAnh Le Tuan Nguyen, View ORCID ProfileJacob George, View ORCID ProfileKaren Canfell, View ORCID ProfileEleonora Feletto
doi: https://doi.org/10.1101/2024.02.20.24303111
Joachim Worthington
1The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW
Emily He
1The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW
Michael Caruana
1The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW
Stephen Wade
1The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW
Barbara de Graaff
3Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania
Anh Le Tuan Nguyen
3Menzies Institute for Medical Research, The University of Tasmania, Hobart, Tasmania
4WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
Jacob George
2Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and University of Sydney
Karen Canfell
1The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW
Eleonora Feletto
1The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW
Data Availability
All data produced in the present work are contained in the manuscript. The modelling in this manuscript is informed by the parameters listed in the appendix.
Posted February 22, 2024.
An economic evaluation of routine hepatocellular carcinoma surveillance for high-risk patients using a novel approach to modelling competing risks
Joachim Worthington, Emily He, Michael Caruana, Stephen Wade, Barbara de Graaff, Anh Le Tuan Nguyen, Jacob George, Karen Canfell, Eleonora Feletto
medRxiv 2024.02.20.24303111; doi: https://doi.org/10.1101/2024.02.20.24303111
An economic evaluation of routine hepatocellular carcinoma surveillance for high-risk patients using a novel approach to modelling competing risks
Joachim Worthington, Emily He, Michael Caruana, Stephen Wade, Barbara de Graaff, Anh Le Tuan Nguyen, Jacob George, Karen Canfell, Eleonora Feletto
medRxiv 2024.02.20.24303111; doi: https://doi.org/10.1101/2024.02.20.24303111
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)